Bienvenu Emile, Mukanyangezi Marie Francoise, Rulisa Stephen, Martner Anna, Hasséus Bengt, Vorontsov Egor, Tobin Gunnar, Giglio Daniel
College of Medicine and Health Sciences, University of Rwanda, KK 737 St, Gikondo, Kigali, Rwanda.
College of Medicine and Health Sciences, University of Rwanda, University Teaching Hospital of Kigali (UTHK), KN 4 Ave, Kigali, Rwanda.
Cancers (Basel). 2021 Nov 28;13(23):5983. doi: 10.3390/cancers13235983.
Effects on the proteome when a high risk (HR)-HPV infection occurs, when it is cleared and when it becomes chronic were investigated. Moreover, biomarker panels that could identify cervical risk lesions were assessed.
Cytology, HPV screening and proteomics were performed on cervical samples from Rwandan HIV+ and HIV- women at baseline, at 9 months, at 18 months and at 24 months. Biological pathways were identified using the String database.
The most significantly affected pathway when an incident HR-HPV infection occurred was neutrophil degranulation, and vesicle-mediated transport was the most significantly affected pathway when an HR-HPV infection was cleared; protein insertion into membrane in chronic HR-HPV lesions and in lesions where HR-HPVs were cleared were compared; and cellular catabolic process in high-grade lesions was compared to that in negative lesions. A four-biomarker panel (EIF1; BLOC1S5; LIMCH1; SGTA) was identified, which was able to distinguish chronic HR-HPV lesions from cleared HR-HPV/negative lesions (sensitivity 100% and specificity 91%). Another four-biomarker panel (ERH; IGKV2-30; TMEM97; DNAJA4) was identified, which was able to distinguish high-grade lesions from low-grade/negative lesions (sensitivity 100% and specificity 81%).
We have identified the biological pathways triggered in HR-HPV infection, when HR-HPV becomes chronic and when cervical risk lesions develop. Moreover, we have identified potential biomarkers that may help to identify women with cervical risk lesions.
研究了高危(HR)-人乳头瘤病毒(HPV)感染发生时、清除时以及变为慢性感染时对蛋白质组的影响。此外,还评估了能够识别宫颈风险病变的生物标志物组合。
对卢旺达HIV阳性和HIV阴性女性的宫颈样本在基线、9个月、18个月和24个月时进行细胞学检查、HPV筛查和蛋白质组学分析。使用String数据库识别生物途径。
新发HR-HPV感染时受影响最显著的途径是中性粒细胞脱颗粒,HR-HPV感染清除时受影响最显著的途径是囊泡介导的转运;比较了慢性HR-HPV病变和HR-HPV清除病变中蛋白质插入膜的情况;比较了高级别病变和阴性病变中的细胞分解代谢过程。确定了一个四生物标志物组合(真核生物翻译起始因子1;BLOC1结构域蛋白5;LIM结构域包含蛋白1;小分子谷胱甘肽转移酶A),其能够区分慢性HR-HPV病变和清除HR-HPV/阴性病变(敏感性为l00%,特异性为91%)。还确定了另一个四生物标志物组合(富含脯氨酸的蛋白质1;免疫球蛋白κ链可变区2-30;跨膜蛋白97;DNAJ热休克蛋白家族成员A4),其能够区分高级别病变和低级别/阴性病变(敏感性为100%,特异性为81%)。
我们已经确定了HR-HPV感染、HR-HPV变为慢性感染以及宫颈风险病变发生时所触发的生物途径。此外,我们还确定了可能有助于识别患有宫颈风险病变女性的潜在生物标志物。